The causes of drug-induced muscle toxicity
Authors:
- Hannah L. KirschHKHannah L. Kirsch
- Robert L. WortmannRWRobert L. Wortmann
- Michael H. PillingerMPMichael H. Pillinger
- 1 November 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 26 (6) , 697-703
Abstract
Clinically identified myopathies are frequently a consequence of medication toxicities. However, recognizing drug-induced myopathies is sometimes difficult. Developing a greater understanding of the underlying mechanisms of drug-induced muscle toxicity will promote enhanced awareness and recognition, and improved management of these syndromes. The adverse impact of certain drugs on muscle metabolism, muscle cell atrophy, and myocyte apoptosis is increasingly clear. Glucocorticoids impair glucose handling and directly promote protein catabolism. Statins impair mitochondrial function and alter intracellular signaling proteins, which can lead to myocyte apoptosis. Alternatively, statins can induce an autoimmune necrotizing myositis. Several medications impair autophagy, thus limiting access to the needed glycogen stores. This review provides an overview of the main underlying mechanisms of drug-induced myopathies. These myopathies will most often be related to a drug's ability to alter metabolism and protein balance, induce necrosis, or impair autophagy.Keywords
This publication has 54 references indexed in Scilit:
- Interaction of the endocrine system with inflammation: a function of energy and volume regulationArthritis Research & Therapy, 2014
- Glucocorticoid-induced skeletal muscle atrophyThe International Journal of Biochemistry & Cell Biology, 2013
- Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell DysfunctionPLOS ONE, 2013
- Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signalingProceedings of the National Academy of Sciences, 2012
- Drugs Causing Muscle DiseaseRheumatic Disease Clinics of North America, 2011
- Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal MuscleCell Metabolism, 2011
- The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 geneAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- The Role of Coenzyme Q10 in Statin-Associated MyopathyJACC, 2007
- Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle AtrophyCell, 2004
- Functional and Histologic Picture of Steroid-Induced Myopathy in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1996